The FDA has granted fast track designation to the investigational oncolytic virus immunotherapy pelareorep (Reolysin) in combination with bevacizumab (Avastin) and FOLFIRI (leucovorin, fluorouracil, ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

Neoadjuvant therapy with immunotherapy in pMMR/MSS rectal cancer shows high response rates and favorable surgical outcomes, with manageable safety profiles. Short-course chemoradiotherapy demonstrates ...

MSS Inc., a Nashville, Tennessee-based manufacturer of sensor-based sorting technology for the recycling and waste management sector, has marked its 50th anniversary. The company, founded in 1973 by ...

Optical sorting equipment manufacturer MSS Inc., headquartered in Nashville, Tennessee, and British technology company Recycleye have announced a strategic partnership in North America that will ...